Loading...
Loading...
BIOSTEM TECHNOLOGIES
BIOSTEM TECHNOLOGIES. Spoken Alpha tracks BSEM's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BSEM's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BSEM.
curl https://api.spokenalpha.com/v1/companies/BSEM| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.71 | $1.46 | +17.3% | +3.0% | +2.4% |
| Q4 FY2026 | $1.72 | $1.40 | +23.2% | +3.2% | +5.0% |
| Q3 FY2026 | $1.70 | $1.39 | +22.1% | -4.0% | -1.7% |
| Q2 FY2026 | $1.80 | $1.48 | +21.5% | -4.0% | -3.7% |
| Q1 FY2025 | $1.73 | $1.42 | +22.0% | -2.6% | -5.6% |
| Q4 FY2025 | $1.95 | $1.66 | +17.4% | -1.7% | -3.1% |
| Q3 FY2025 | $1.87 | $1.57 | +18.8% | +1.7% | +1.3% |
| Q2 FY2025 | $2.03 | $1.71 | +18.5% | -2.5% | -3.5% |
| Q1 FY2024 | $2.14 | $1.72 | +24.6% | -0.3% | +1.3% |
| Q4 FY2024 | $2.24 | $1.74 | +29.0% | -2.4% | -1.0% |